I now have enough from the library to construct thorough ANS pharmacology notes. Let me now write the complete, exam-ready notes in KD Tripathi/Shankar Bhag style.
🧠 ANS Pharmacology - Exam Notes
As per KD Tripathi (Essentials of Medical Pharmacology) & Shankar Bhag (Pharmacology for Medical Graduates)
MBBS 2nd Year | University Exam Focused
UNIT 1: OVERVIEW OF AUTONOMIC NERVOUS SYSTEM
Organization of ANS
| Feature | Sympathetic | Parasympathetic |
|---|
| Origin | Thoracolumbar (T1-L2) | Craniosacral (CN III, VII, IX, X; S2-S4) |
| Preganglionic fiber | Short | Long |
| Postganglionic fiber | Long | Short |
| Ganglia location | Close to spinal cord | Close to/in target organ |
| NT at preganglionic | ACh (Nicotinic) | ACh (Nicotinic) |
| NT at postganglionic | Noradrenaline | ACh (Muscarinic) |
| Exception | Sweat glands, adrenal medulla (ACh) | - |
Exam Tip: Both sympathetic and parasympathetic preganglionic fibers release ACh acting on Nicotinic (NN) receptors. Only the postganglionic fibers differ.
UNIT 2: NEUROHUMORAL TRANSMISSION
Cholinergic Transmission (ACh)
Steps in ACh synthesis and release:
- Choline enters nerve terminal via Na+-dependent choline transporter (CHT) - blocked by hemicholinium
- ACh synthesized by choline acetyltransferase (ChAT) from choline + Acetyl-CoA
- ACh stored in vesicles via vesicular ACh transporter (VAT) - blocked by vesamicol
- Ca2+ influx triggers vesicle fusion and ACh release - blocked by botulinum toxin
- ACh broken down in synapse by acetylcholinesterase (AChE)
- Choline recycled back into presynaptic terminal
Mnemonic for ACh blockers: "He Visits Beautiful Girls" = Hemicholinium (CHT) → Vesamicol (VAT) → Botulinum toxin (release)
Adrenergic Transmission (NA/Adrenaline)
Steps:
- Tyrosine → DOPA (by tyrosine hydroxylase - rate-limiting step)
- DOPA → Dopamine (by DOPA decarboxylase)
- Dopamine → Noradrenaline in vesicles (by dopamine-β-hydroxylase)
- Noradrenaline → Adrenaline in adrenal medulla (by PNMT - phenylethanolamine-N-methyl transferase)
- NA release into synapse
- Termination: mainly by reuptake (Uptake-1) into presynaptic terminal; also by MAO (monoamine oxidase) and COMT (catechol-O-methyl transferase)
Exam Tip: Reuptake (Uptake-1) is the main mechanism of NA termination (unlike ACh which is enzymatically destroyed).
UNIT 3: CHOLINERGIC RECEPTORS
Muscarinic Receptors (M1-M5) - G-protein coupled
| Receptor | Location | Mechanism | Effect |
|---|
| M1 | Gastric parietal cells, CNS, autonomic ganglia | Gq → ↑IP3/DAG | ↑Gastric acid secretion |
| M2 | Heart (SA node, AV node) | Gi → ↓cAMP | ↓HR, ↓conduction |
| M3 | Smooth muscle, exocrine glands, eye | Gq → ↑IP3/DAG | Contraction, secretion, miosis |
| M4 | CNS | Gi | CNS effects |
| M5 | CNS, iris | Gq | Ocular effects |
Nicotinic Receptors - Ion channel (Na+/K+)
| Receptor | Location | Effect |
|---|
| NN (ganglionic) | All autonomic ganglia | Ganglionic transmission |
| NM (neuromuscular) | Skeletal muscle endplate | Muscle contraction |
Exam Tip: Muscarinic = Metabotropic (G-protein). Nicotinic = Ionotropic (ion channel).
UNIT 4: CHOLINOMIMETIC DRUGS (Parasympathomimetics)
Classification (KD Tripathi style):
A. Direct acting (act on cholinergic receptors directly)
| Drug | Type | Selectivity | Key Use |
|---|
| Acetylcholine | Choline ester | Non-selective | No clinical use (too short-acting) |
| Carbachol | Choline ester | Muscarinic + Nicotinic | Glaucoma (eye drops) |
| Bethanechol | Choline ester | Muscarinic only | Urinary retention, post-op ileus |
| Pilocarpine | Alkaloid | Muscarinic | Glaucoma (drug of choice), Xerostomia in Sjogren's |
| Muscarine | Alkaloid | Muscarinic | Mushroom poisoning (no clinical use) |
Mnemonic: "Can Bill Please Make Music" = Carbachol, Bethanechol, Pilocarpine, Muscarine, (Methacholine)
B. Indirect acting - Anticholinesterases (inhibit AChE → ↑ACh)
| Drug | Type | Duration | Key Uses |
|---|
| Neostigmine | Carbamate (reversible) | Short | Myasthenia gravis, post-op reversal of NMB, urinary retention |
| Physostigmine | Carbamate (reversible) | Short | Glaucoma, atropine poisoning antidote |
| Pyridostigmine | Carbamate (reversible) | Medium | Myasthenia gravis (drug of choice) |
| Edrophonium | Quaternary ammonium (reversible) | Very short (5 min) | Tensilon test - diagnosis of MG |
| Organophosphates (Malathion, Parathion, Echothiophate) | Irreversible | Permanent | Glaucoma (echothiophate), Insecticides |
| Echothiophate | Irreversible organophosphate | Long | Glaucoma (eye drops) |
Exam Tip (Frequently asked): Edrophonium = Tensilon Test for MG diagnosis. Pyridostigmine = treatment of MG. Atropine + Pralidoxime = treatment of organophosphate poisoning.
Organophosphate Poisoning - SLUDGE mnemonic
SLUDGE = Salivation, Lacrimation, Urination, Defecation, GI cramps, Emesis
- Also: Miosis, bradycardia, bronchospasm, bronchorrhea
- Treatment: Atropine (for muscarinic effects) + Pralidoxime/2-PAM (reactivates AChE - must be given early before "aging")
UNIT 5: ANTICHOLINERGIC DRUGS (Parasympatholytics)
Classification:
| Drug | Key Features |
|---|
| Atropine | Prototype; non-selective muscarinic antagonist |
| Scopolamine (Hyoscine) | More CNS penetration; anti-motion sickness, pre-anesthetic |
| Homatropine | Eye use (cycloplegia) |
| Tropicamide | Eye use (shortest acting mydriatic) |
| Ipratropium | Inhaled; COPD/asthma (no CNS effects - quaternary) |
| Tiotropium | Long-acting inhaled; COPD (once daily) |
| Dicyclomine | IBS, smooth muscle spasm |
| Benzhexol (Trihexyphenidyl) | Parkinsonism |
| Pirenzepine | M1 selective; peptic ulcer (reduces acid) |
Atropine - Pharmacological Effects
| System | Effect |
|---|
| Eye | Mydriasis (dilated pupil), cycloplegia (loss of accommodation) |
| Heart | ↑HR (tachycardia) - blocks vagal M2 |
| Smooth muscle | Relaxation (↓GI motility, bronchodilation, ↓bladder tone) |
| Secretions | ↓Saliva (dry mouth), ↓sweat, ↓lacrimation |
| CNS | Restlessness, hallucination (high dose); sedation (scopolamine > atropine) |
Dose-dependent effects of Atropine (Exam classic!):
| Dose | Effect |
|---|
| 0.5 mg | Slight bradycardia, dry mouth |
| 1 mg | Dry mouth, thirst, tachycardia |
| 2 mg | Tachycardia, palpitation, dry skin, mydriasis |
| 5 mg | Urinary retention, constipation, difficulty speaking |
| >10 mg | Delirium, hallucinations, coma |
Mnemonic for Atropine toxicity: "Dry as a bone, Blind as a bat, Mad as a hatter, Red as a beet, Hot as a hare"
Uses of Atropine:
- Premedication (↓secretions before anesthesia)
- Organophosphate poisoning (antidote)
- Bradycardia (cardiac emergencies)
- Ophthalmology (mydriasis, cycloplegia)
- Peptic ulcer (pirenzepine preferred)
- Motion sickness (scopolamine preferred)
UNIT 6: ADRENERGIC RECEPTORS
Alpha (α) Receptors
| Receptor | Location | Effect |
|---|
| α1 | Vascular smooth muscle, iris, prostate | Vasoconstriction, mydriasis, ↑urethral tone |
| α2 | Presynaptic (autoreceptor), platelets, fat cells | ↓NA release (feedback inhibition), platelet aggregation |
Mechanism: α1 = Gq (↑IP3/DAG). α2 = Gi (↓cAMP)
Beta (β) Receptors
| Receptor | Location | Effect |
|---|
| β1 | Heart, kidney | ↑HR, ↑contractility, ↑renin release |
| β2 | Bronchi, uterus, vascular smooth muscle, liver | Bronchodilation, uterine relaxation, vasodilation, glycogenolysis |
| β3 | Fat cells | Lipolysis |
Mechanism: All β = Gs (↑cAMP)
Exam Tip: β1 = mainly heart (1 heart). β2 = mainly lungs/bronchi (2 lungs).
Dopamine Receptors (D1, D2):
- D1: renal/mesenteric vasodilation (low dose dopamine effect)
- D2: presynaptic inhibition of NA release
UNIT 7: SYMPATHOMIMETIC DRUGS (Adrenergic Agonists)
Classification:
A. Direct acting:
| Drug | Receptors | Key Effects/Uses |
|---|
| Adrenaline (Epinephrine) | α1, α2, β1, β2 (all) | Anaphylaxis (DOC), cardiac arrest, local anesthetic adjunct |
| Noradrenaline (Norepinephrine) | α1, α2, β1 (no β2) | Vasopressor in shock |
| Isoprenaline (Isoproterenol) | β1, β2 (pure β) | AV block, bronchospasm (rarely used now) |
| Salbutamol (Albuterol) | β2 selective | Acute asthma (DOC), premature labor (tocolysis) |
| Salmeterol/Formoterol | β2 selective (long-acting) | Prophylaxis of asthma, COPD |
| Dobutamine | β1 selective | Cardiogenic shock, cardiac failure (↑contractility) |
| Dopamine | D1, β1, α1 (dose-dependent) | Shock with renal impairment |
| Phenylephrine | α1 selective | Nasal decongestant, mydriasis |
| Clonidine | α2 selective (central) | Hypertension, ADHD, opioid withdrawal |
B. Indirect acting:
- Amphetamine - releases NA from nerve terminals; CNS stimulant
- Tyramine - found in cheese, red wine; releases NA (cheese reaction with MAO inhibitors)
C. Mixed acting:
- Ephedrine - direct + indirect; used in hypotension under anesthesia, nasal decongestant
Dopamine - Dose-Dependent Effects (Exam Favourite!):
| Dose (mcg/kg/min) | Receptors Activated | Effect |
|---|
| Low: 1-3 | D1 | Renal/splanchnic vasodilation, ↑urine output |
| Medium: 3-10 | β1 | ↑HR, ↑contractility |
| High: >10 | α1 | Vasoconstriction (↑BP) |
Adrenaline vs Noradrenaline (Classic Comparison):
| Feature | Adrenaline | Noradrenaline |
|---|
| α1 effect | Yes | Yes (stronger) |
| β1 effect | Yes | Yes |
| β2 effect | Yes | No |
| Net BP | ↑Systolic, ↓Diastolic → ↑pulse pressure | ↑Both systolic and diastolic |
| Heart rate | ↑ (direct + reflex) | ↓ (reflex bradycardia) |
| Peripheral resistance | ↓ (β2 vasodilation predominates) | ↑↑ (only vasoconstriction) |
| Use | Anaphylaxis, cardiac arrest | Vasopressor in shock |
UNIT 8: ADRENERGIC BLOCKERS
Alpha Blockers (α-Blockers)
A. Non-selective (α1 + α2):
| Drug | Type | Use |
|---|
| Phentolamine | Reversible | Phaeochromocytoma diagnosis/surgery, erectile dysfunction |
| Phenoxybenzamine | Irreversible (non-competitive) | Phaeochromocytoma (long-term) |
B. Selective α1 blockers:
| Drug | Use |
|---|
| Prazosin | Hypertension (first-dose hypotension - warn patient!) |
| Terazosin, Doxazosin | Hypertension, BPH |
| Tamsulosin | BPH (most selective for prostate α1A) |
Exam Tip: Phenoxybenzamine = irreversible (can only be overcome by synthesis of new receptors). "Pheno-never-blocks-amine"
Adrenaline Reversal (Dale's Vasomotor Reversal):
- Normally adrenaline → ↑BP (α1 effect)
- After phentolamine/phenoxybenzamine → adrenaline causes ↓BP (because α1 is blocked, only β2 vasodilation acts)
- Exam tip: This is called adrenaline reversal or Dale's phenomenon
Beta Blockers (β-Blockers)
Classification:
| Drug | Selectivity | ISA | Extra property |
|---|
| Propranolol | Non-selective (β1+β2) | No | Prototype; membrane stabilizing activity (MSA) |
| Atenolol | β1 selective (cardioselective) | No | Hypertension, angina |
| Metoprolol | β1 selective | No | Heart failure (carvedilol/bisoprolol preferred) |
| Bisoprolol | β1 selective (highest) | No | Heart failure |
| Pindolol | Non-selective | Yes | Least bradycardia |
| Acebutolol | β1 selective | Yes | - |
| Carvedilol | Non-selective + α1 block | No | Heart failure (vasodilation + β block) |
| Labetalol | Non-selective + α1 block | No | Hypertensive emergencies in pregnancy |
| Sotalol | Non-selective | No | Antiarrhythmic (Class III) |
| Timolol | Non-selective | No | Glaucoma (eye drops) |
| Betaxolol | β1 selective | No | Glaucoma |
| Celiprolol | β1 + β2 agonist | Partial β2 agonism | COPD patients |
ISA (Intrinsic Sympathomimetic Activity) = partial agonist activity at β receptors = less resting bradycardia and less decrease in resting cardiac output.
Pharmacological Effects of Beta Blockers:
| System | Effect |
|---|
| Heart | ↓HR, ↓contractility, ↓CO, ↓AV conduction |
| BP | ↓BP (chronic use) |
| Bronchi | Bronchoconstriction (avoid in asthma - use cardioselective if must) |
| Metabolic | Mask hypoglycemia symptoms (avoid in DM on insulin), ↑TG |
| Eye | ↓IOP (↓aqueous humor production) |
Uses of Beta Blockers:
- Hypertension
- Angina pectoris
- Myocardial infarction (post-MI - ↓mortality)
- Heart failure (carvedilol, metoprolol, bisoprolol)
- Arrhythmias
- Glaucoma (timolol eye drops)
- Thyrotoxicosis (propranolol - controls symptoms)
- Anxiety/tremor (propranolol)
- Migraine prophylaxis (propranolol)
- Phaeochromocytoma (only AFTER alpha blockade!)
Contraindications of Beta Blockers:
- Asthma/COPD (bronchoconstriction)
- Heart block (worsens AV conduction)
- Cardiogenic shock (↓HR and contractility)
- Peripheral vascular disease (Raynaud's - β2 block causes vasoconstriction)
- Diabetes on insulin (masks hypoglycemia)
Exam Tip: In phaeochromocytoma, NEVER give beta blocker alone (causes unopposed α vasoconstriction → hypertensive crisis). Always give alpha blocker first, then beta blocker.
UNIT 9: HIGH-YIELD EXAM POINTS (One-Liners)
| Point | Answer |
|---|
| Drug of choice - Anaphylaxis | Adrenaline (IM) |
| Drug of choice - Myasthenia Gravis (treatment) | Pyridostigmine |
| Drug of choice - Myasthenia Gravis (diagnosis) | Edrophonium (Tensilon test) |
| Drug of choice - Organophosphate poisoning | Atropine + Pralidoxime |
| Drug of choice - Glaucoma (acute angle closure) | Pilocarpine |
| Drug of choice - COPD bronchodilator (inhaled) | Ipratropium/Tiotropium |
| Drug of choice - Asthma acute attack | Salbutamol (β2 agonist) |
| Drug of choice - BPH | Tamsulosin |
| Drug used in Phaeochromocytoma | Phenoxybenzamine (irreversible α-blocker) |
| Drug causing "first-dose hypotension" | Prazosin |
| Dale's vasomotor reversal | After α-blocker, adrenaline ↓BP instead of ↑BP |
| Rate-limiting enzyme in catecholamine synthesis | Tyrosine hydroxylase |
| Drug that "ages" AChE (making pralidoxime ineffective) | Organophosphates (irreversible) |
| Mydriatic with shortest duration | Tropicamide |
| β-blocker used in glaucoma | Timolol (eye drops) |
| β-blocker with alpha blocking property | Carvedilol, Labetalol |
| Which β-blocker is used in heart failure? | Carvedilol, Bisoprolol, Metoprolol-XR |
| Anticholinergic used for motion sickness | Scopolamine (Hyoscine) |
| Drug for mushroom (Amanita) poisoning | Atropine |
UNIT 10: IMPORTANT COMPARISONS (Short Answer / SAQ Type)
Muscarinic vs Nicotinic effects of ACh:
| Effect | Muscarinic | Nicotinic |
|---|
| Eye | Miosis | - |
| Heart | ↓HR, ↓BP | - |
| Bronchi | Constriction | - |
| GI | ↑Motility, ↑secretions | - |
| Bladder | Contraction | - |
| Ganglia | - | Stimulation |
| Skeletal muscle | - | Contraction |
Reversible vs Irreversible Anticholinesterases:
| Feature | Reversible | Irreversible |
|---|
| Drugs | Neostigmine, physostigmine, edrophonium, pyridostigmine | Organophosphates (malathion, parathion, DFP, TOCP) |
| Bond with AChE | Carbamylation (transient) | Phosphorylation (permanent) |
| Treatment of toxicity | Atropine | Atropine + Pralidoxime |
| Pralidoxime effective? | Yes | Yes (only if given early, before aging) |
UNIT 11: NEUROMUSCULAR BLOCKING DRUGS (NMBDs)
Classification:
A. Non-depolarizing (Competitive) blockers:
| Drug | Duration | Key Points |
|---|
| Tubocurarine | Long | Prototype; histamine release, hypotension |
| Pancuronium | Long | ↑HR (vagolytic), no histamine |
| Vecuronium | Intermediate | No cardiovascular effects; ideal |
| Atracurium | Intermediate | Hofmann elimination (safe in liver/renal failure) |
| Cisatracurium | Intermediate | Less histamine than atracurium |
| Rocuronium | Intermediate | Fastest onset among non-depolarizing; used for RSI |
| Mivacurium | Short | Metabolized by pseudocholinesterase |
Reversal: Neostigmine (+ atropine to prevent bradycardia), or Sugammadex (reverses rocuronium/vecuronium specifically)
B. Depolarizing blockers:
| Drug | Notes |
|---|
| Succinylcholine (Suxamethonium) | Only one in use; fastest onset (60 sec) and shortest action; used for intubation, RSI; metabolized by pseudocholinesterase |
Complications of Succinylcholine:
- Malignant hyperthermia (with halothane)
- Hyperkalemia (contraindicated in burns, crush injury, denervation)
- Muscle pains (fasciculations → post-op myalgia)
- Prolonged apnea in pseudocholinesterase deficiency
SUMMARY DIAGRAM - ANS Drug Classification
ANS Pharmacology
├── CHOLINERGIC DRUGS
│ ├── Agonists (Parasympathomimetics)
│ │ ├── Direct: ACh, Carbachol, Bethanechol, Pilocarpine
│ │ └── Indirect (AChE inhibitors): Neostigmine, Physostigmine, Pyridostigmine,
│ │ Edrophonium, Organophosphates
│ └── Antagonists (Parasympatholytics/Anticholinergics)
│ ├── Non-selective: Atropine, Scopolamine
│ └── Selective: Pirenzepine (M1), Ipratropium, Tiotropium
│
└── ADRENERGIC DRUGS
├── Agonists (Sympathomimetics)
│ ├── Non-selective: Adrenaline, Noradrenaline, Isoprenaline
│ ├── α selective: Phenylephrine (α1), Clonidine (α2)
│ └── β selective: Salbutamol, Salmeterol (β2), Dobutamine (β1)
└── Antagonists (Sympatholytics)
├── α blockers: Phentolamine, Phenoxybenzamine, Prazosin, Tamsulosin
└── β blockers: Propranolol, Atenolol, Metoprolol, Carvedilol, Labetalol
QUICK REVISION MNEMONICS
| Mnemonic | Topic |
|---|
| SLUDGE | Cholinergic (organophosphate) toxicity symptoms |
| Dry as a bone, Blind as a bat, Mad as a hatter, Red as a beet, Hot as a hare | Atropine toxicity |
| "HVB" | ACh synthesis blockers: Hemicholinium → Vesamicol → Botulinum toxin |
| "3 β1 = Heart" | β1 effects: ↑HR, ↑Force, ↑Renin |
| ABCDE of β-blockers | Angina, BP, CHF (cardiac failure), Death (post-MI), Eye (glaucoma) |
| "First DOC then TrIAC" | Cholinomimetics in glaucoma: Pilocarpine (DOC), then if fails → Timolol → Acetazolamide |
Sources: Ganong's Review of Medical Physiology (Cholinergic/Adrenergic receptor details), Katzung's Basic & Clinical Pharmacology (receptor pharmacology, drug classification), Goodman & Gilman (anticholinesterase poisoning, adrenergic mechanisms) - cross-referenced with KD Tripathi and Shankar Bhag structure.
These notes cover all major ANS pharmacology topics for MBBS 2nd year university exams. Topics presented match KD Tripathi chapter sequence (Chapters 4-9 of KD Tripathi's Essentials of Medical Pharmacology) and Shankar Bhag's format. Let me know if you want any specific topic expanded (e.g., detailed NMBDs, individual drug tables, long answer formats, or MCQ lists).